Physician profile
Randy W Smith
NPI 1235136938
$1,278.12
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $330 · 2021: $453 · 2022: $40.60 · 2023: $82.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $309.63 | 2020-2021 | |
| Astellas Pharma US INC | $119.70 | 2019-2021 | |
| Abiomed | $82.36 | 2023 | Impella |
| Duchesnay USA Incorporated | $81.85 | 2019 | |
| Pfizer INC. | $71.12 | 2019-2021 | |
| Hologic Sales and Service, LLC | $62.76 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $60.11 | 2019-2021 | |
| Lupin INC. | $59.73 | 2020-2021 | |
| Exeltis, USA INC. | $55.96 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $43.79 | 2019 | |
| Roche Diagnostics Corporation | $42.11 | 2019 | |
| Allergan, INC. | $41.64 | 2019 | |
| Boston Scientific Corporation | $40.60 | 2022 | |
| Therapeuticsmd, INC. | $39.19 | 2020 | |
| Meditrina | $37.29 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $33.03 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.73 | 2019 | |
| Scynexis, INC. | $20.14 | 2021 | |
| Mayne Pharma Commercial LLC | $19.75 | 2021 | |
| Coopersurgical, INC. | $18.56 | 2020 | |
| Avion Pharmaceuticals | $14.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.